News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,016 Results
Type
Article (6479)
Company Profile (20)
Press Release (98517)
Section
Business (31300)
Career Advice (220)
Deals (4881)
Drug Delivery (5)
Drug Development (9133)
Employer Resources (11)
FDA (2938)
Job Trends (2986)
News (50576)
Policy (5519)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (675)
Academic (1)
Allergies (14)
Alliances (10062)
ALS (6)
Alzheimer's disease (185)
Antibody-drug conjugate (ADC) (13)
Approvals (2975)
Artificial intelligence (32)
Automation (8)
Bankruptcy (26)
Best Places to Work (2314)
BIOSECURE Act (1)
Biosimilars (4)
Biotechnology (14)
Bladder cancer (9)
Brain cancer (4)
Breast cancer (48)
Cancer (332)
Cardiovascular disease (18)
Career advice (201)
Career pathing (1)
CAR-T (22)
Cell therapy (48)
Cervical cancer (6)
Clinical research (7063)
Collaboration (134)
Compensation (2)
Complete response letters (3)
COVID-19 (553)
CRISPR (5)
C-suite (18)
Cystic fibrosis (7)
Data (276)
Depression (1)
Diabetes (25)
Diagnostics (3160)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (18)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (8907)
Employer branding (3)
Employer resources (9)
Events (10498)
Executive appointments (93)
FDA (3074)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (77)
Gene editing (7)
Generative AI (3)
Gene therapy (34)
GLP-1 (103)
Government (909)
Grass and pollen (3)
Guidances (5)
Healthcare (2339)
Immunology and inflammation (4)
Indications (3)
Infectious disease (577)
Inflammatory bowel disease (7)
Influenza (9)
Intellectual property (9)
Interviews (28)
IPO (1443)
Job creations (785)
Job search strategy (187)
Kidney cancer (1)
Labor market (2)
Layoffs (32)
Leadership (1)
Legal (1122)
Liver cancer (8)
Lung cancer (59)
Lymphoma (25)
Machine learning (1)
Management (3)
Manufacturing (48)
MASH (2)
Medical device (1415)
Medtech (1415)
Mergers & acquisitions (3503)
Metabolic disorders (42)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (218)
NextGen: Class of 2025 (842)
Non-profit (624)
Northern California (234)
Now hiring (11)
Obesity (17)
Opinion (15)
Ovarian cancer (4)
Pain (5)
Pancreatic cancer (7)
Parkinson's disease (13)
Partnered (4)
Patents (15)
Patient recruitment (5)
Peanut (9)
People (9512)
Pharmaceutical (6)
Phase I (2067)
Phase II (2759)
Phase III (2731)
Pipeline (99)
Policy (1)
Postmarket research (395)
Preclinical (1213)
Press Release (18)
Prostate cancer (21)
Psychedelics (2)
Radiopharmaceuticals (30)
Rare diseases (28)
Real estate (1979)
Recruiting (4)
Regulatory (3774)
Reports (7)
Research institute (642)
Resumes & cover letters (24)
RSV (3)
Series A (12)
Series B (7)
Sickle cell disease (5)
Southern California (239)
Spinal muscular atrophy (36)
Sponsored (6)
Startups (637)
State (1)
Stomach cancer (1)
Supply chain (9)
United States (2537)
Vaccines (50)
Venture capitalists (1)
Webinars (3)
Weight loss (11)
Women's health (3)
Date
Today (13)
Last 7 days (68)
Last 30 days (328)
Last 365 days (4280)
2025 (862)
2024 (4500)
2023 (5320)
2022 (8923)
2021 (9354)
2020 (9293)
2019 (6337)
2018 (4879)
2017 (5211)
2016 (5323)
2015 (5878)
2014 (4723)
2013 (4206)
2012 (4462)
2011 (4548)
2010 (4078)
Location
Africa (132)
Alabama (10)
Alaska (1)
Arizona (32)
Arkansas (3)
Asia (6378)
Australia (1085)
California (585)
Canada (244)
China (25)
Colorado (35)
Connecticut (30)
Delaware (22)
Europe (14113)
Florida (80)
Georgia (10)
Idaho (7)
Illinois (39)
India (2)
Indiana (37)
Iowa (2)
Japan (14)
Kansas (22)
Kentucky (4)
Louisiana (1)
Maine (23)
Maryland (100)
Massachusetts (375)
Michigan (55)
Minnesota (32)
Missouri (32)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (256)
New Mexico (8)
New York (194)
North Carolina (140)
North Dakota (1)
Northern California (234)
Ohio (37)
Oklahoma (3)
Oregon (3)
Pennsylvania (104)
Rhode Island (9)
South America (196)
South Carolina (3)
Southern California (239)
Tennessee (17)
Texas (148)
Utah (40)
Virginia (11)
Washington D.C. (4)
Washington State (78)
Wisconsin (8)
105,016 Results for "advent laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.
October 2, 2023
·
4 min read
Pharm Country
Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy
Advent Therapeutics, Inc. has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB grant.
July 18, 2023
·
8 min read
Genetown
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Boston Scientific Corporation announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed Field Ablation System*, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation.
August 27, 2023
·
6 min read
FDA
Advent Therapeutics Receives FDA Rare Pediatric Disease Designation for Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants
Advent Therapeutics, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Designation (RPDD) for its vitamin A metabolic and reparative respiratory drugs for the prevention of Bronchopulmonary Dysplasia (BPD) in premature infants.
July 20, 2023
·
3 min read
BioMidwest
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
Baxter International Inc., a leading global medtech company, announced that it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
May 8, 2023
·
9 min read
BioCapital
Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility
Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”) and Advent BioServices jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) for commercial manufacturing of cell therapy products at the GMP facility in Sawston, U.K.
March 20, 2023
·
5 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
Crown Laboratories Completes Acquisition of Revance Therapeutics
February 7, 2025
·
3 min read
Press Releases
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
February 20, 2025
·
3 min read
Press Releases
Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
February 6, 2025
·
4 min read
1 of 10,502
Next
